The partnership is expected to enable a seamless integration of study conduct with full CRO services, including project management, monitoring, quality assurance, data management, biostatistics, and medical writing.
Gary Slizgi, CEO of Clinesian, said: “Both companies have extensive experience in the pharmaceutical industry. Furthermore, our CRO expertise in Phase I and Advanced Clinical Research Institute’s (ACRI’s) proven track record as a Phase I research facility will make this strategic alliance a powerful fit.”